ACHE and myasthenia gravis: In addition to AD, reversible AChE inhibitors of various chemical structures have noteworthy pharmacological application in the treatment of neurological disorders manifestations such as myasthenia gravis, Lewy bodies and Parkinson’s disease dementia, and as prophylactics against nerve agent intoxication as well.